[go: up one dir, main page]

FR2387653A1 - Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparation - Google Patents

Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparation

Info

Publication number
FR2387653A1
FR2387653A1 FR7810680A FR7810680A FR2387653A1 FR 2387653 A1 FR2387653 A1 FR 2387653A1 FR 7810680 A FR7810680 A FR 7810680A FR 7810680 A FR7810680 A FR 7810680A FR 2387653 A1 FR2387653 A1 FR 2387653A1
Authority
FR
France
Prior art keywords
weight
sterile aqueous
substance based
preparation
intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7810680A
Other languages
English (en)
Other versions
FR2387653B1 (fr
Inventor
Bjorn Gustaf-Adolf Ingelman
Ary Wolfgang Richter
Kirsti Anni Granath-Nee-Taitto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of FR2387653A1 publication Critical patent/FR2387653A1/fr
Application granted granted Critical
Publication of FR2387653B1 publication Critical patent/FR2387653B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

Solution aqueuse stérile contenant une substance à base d'hydrates de carbone. La solution contient, pour 100 ml de solution, 0,01 à 35 g d'un mélange d'isomalto-oligosaccharides, lequel contient : a. 0 à 15 % en poids d'isomaltose, b. 20 à 65 % en poids d'isomaltotriose, d'isomaltotétraose et d'isomaltopentaose, chacun de ces oligosaccharides étant présents en une quantité comprise entre 5 et 25 % en poids, c. 20 à 65 % en poids d'isomaltohexaose, d'isomaltoheptaose, d'isomaltooctaose et d'isomaltononaose, l'isomaltohexaose et l'isomaltoheptaose étant présents en une quantité comprise entre 5 et 25 % en poids, et d. 0 à 30 % en poids d'isomalto-oligosaccharides renfermant de 10 à 20 maillons glucose, les pourcentages étant calculés sur le poids total du mélange d'isomalto-oligosaccharides. L'invention est applicable à des traitements médicaux par voie parentérale.
FR7810680A 1977-04-19 1978-04-11 Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparation Granted FR2387653A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16162/77A GB1594697A (en) 1977-04-19 1977-04-19 Oligosaccharide compositions for parenteral use

Publications (2)

Publication Number Publication Date
FR2387653A1 true FR2387653A1 (fr) 1978-11-17
FR2387653B1 FR2387653B1 (fr) 1980-08-01

Family

ID=10072281

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7810680A Granted FR2387653A1 (fr) 1977-04-19 1978-04-11 Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparation

Country Status (14)

Country Link
US (1) US4201772A (fr)
JP (1) JPS542314A (fr)
AT (1) AT370114B (fr)
BE (1) BE866092A (fr)
CA (1) CA1094452A (fr)
CH (1) CH641353A5 (fr)
DE (1) DE2815967C2 (fr)
DK (1) DK158627C (fr)
ES (1) ES468867A1 (fr)
FR (1) FR2387653A1 (fr)
GB (1) GB1594697A (fr)
IT (1) IT1103077B (fr)
NL (1) NL188387C (fr)
SE (1) SE443509B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE427983B (sv) * 1980-02-15 1983-05-30 Pripps Bryggerier Ab Dryckesprodukt
DE3113035A1 (de) * 1981-04-01 1982-10-21 Laboratorien Hausmann AG, 9001 St. Gallen Verfahren zur herstellung eines hohen anteil an isomaltopentaose und isomaltohexaose aufweisenden gemisches, dessen verwendung und es enthaltende sterile waessrige loesung
US4518581A (en) * 1981-11-02 1985-05-21 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Imparting low- or anti-cariogenic property to orally-usable products
JPS61227777A (ja) * 1985-04-02 1986-10-09 Showa Sangyo Kk ビフイズス菌生育活性剤
JPS63143505U (fr) * 1987-03-11 1988-09-21
EP0928222B2 (fr) * 1995-09-12 2007-03-21 M&J Industries A/S Broyeuse
JPH11100401A (ja) * 1997-07-30 1999-04-13 Kikkoman Corp 環状オリゴ糖及びそれを含むレトロウイルス性疾患の予防または治療剤
US20030203072A1 (en) * 2002-04-26 2003-10-30 Team Nrg, Inc. Rehydration beverage
UA103373C2 (ru) 2009-03-25 2013-10-10 Фармакосмос Голдинг А/С Стабильное соединение феррума олигосахарида
GB201020300D0 (en) 2010-11-30 2011-01-12 Vitrolife Sweden Ab Product

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2708174A (en) * 1952-11-15 1955-05-10 Commercial Solvents Corp Clinical dextran composition

Also Published As

Publication number Publication date
CA1094452A (fr) 1981-01-27
SE443509B (sv) 1986-03-03
IT7809419A0 (it) 1978-04-18
NL188387C (nl) 1992-06-16
SE7803404L (sv) 1978-10-20
ES468867A1 (es) 1979-09-16
AT370114B (de) 1983-03-10
DK169378A (da) 1978-10-20
US4201772A (en) 1980-05-06
NL7804147A (nl) 1978-10-23
DE2815967A1 (de) 1978-10-26
JPS542314A (en) 1979-01-09
FR2387653B1 (fr) 1980-08-01
ATA268678A (de) 1980-09-15
CH641353A5 (de) 1984-02-29
GB1594697A (en) 1981-08-05
DK158627C (da) 1990-11-19
DE2815967C2 (de) 1986-07-31
BE866092A (fr) 1978-10-18
JPS6237007B2 (fr) 1987-08-10
IT1103077B (it) 1985-10-14
DK158627B (da) 1990-06-25
NL188387B (nl) 1992-01-16

Similar Documents

Publication Publication Date Title
Barker et al. The mechanism of auricular paroxysmal tachycardia
Perkins Serious verapamil poisoning: treatment with intravenous calcium gluconate
Surawicz et al. Effect of potassium and calcium deficiency on the monophasic action potential, electrocardiogram and contractility of isolated rabbit hearts
FR2387653A1 (fr) Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparation
BELLET The electrocardiogram in electrolyte imbalance
Barnes et al. Electrocardiographic changes in amitriptyline poisoning
FR2406999A1 (fr) Stabilisant pour polysaccharides de meningocoques
Niwa et al. A new potent β-glucuronidase inhibitor, D-glucaro-δ-lactam derived from nojirimycin
McKusick The effect of lithium on the electrocardiogram of animals and relation of this effect to the ratio of the intracellular and extracellular concentrations of potassium
Page et al. Interrelationships between cardiac effects of ouabain, hypocalcemia and hyperkalemia
Staley et al. Crossbands of Caulobacter crescentus stalks serve as indicators of cell age
OLINGER Mixed infection in subacute bacterial endocarditis: report of two cases
GB1378068A (en) Citric acid derivatives
Kleinfeld et al. Electrocardiographic manifestations of hypocalcemia produced with ethylenediamine tetraacetic acid
FR2401139A2 (fr) Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant
Bellet et al. Effect of molar sodium lactate in increasing cardiac rhythmicity: Clinical and experimental study of its use in the treatment of patients with slow heart rates, Stokes-Adams syndrome, and episodes of cardiac arrest
Burghuber et al. Decreased prostacyclin sensitivity of human platelets after jogging and squash
Senges et al. Combined effects of glucose and hypoxia on cardiac automaticity and conduction
FR2372629A1 (fr) Nouvel antibiotique et son procede de preparation
Prasad et al. Electrophysiologic basis of use of a polarizing solution in the treatment of myocardial infarction
FR2414556A1 (fr) Procede de preparation d'hydrolysats d'amidon contenant du maltose, et de production de maltose par cristallisation a partir de ces hydrolysats
Follath et al. Unusual electrocardiographic changes in Ebstein's anomaly
KR880013562A (ko) 7-티아프로스타글란딘e₁ 또는 그의 유도체를 함유하는 당뇨병치료 조성물
KR880013936A (ko) 강심성 트리사이클릭 이미다졸론
Giacoia et al. Q-oTc interval and blood calcium levels in newborn infants

Legal Events

Date Code Title Description
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0462, 920619

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0462, 780411

CL Concession to grant licences
CD Change of name or company name
TP Transmission of property